African Union Commission launches CONCVACT to develop COVID-19 vaccine

AFRICA – The African Union Commission has launched the Africa Centres for Disease Control and Prevention Consortium for COVID-19 Vaccine Clinical Trial – CONCVACT, to bring together global vaccine developers, funders, and African organizations that conduct clinical trials. AU said it is meant to ensure that over 10 late-stage trials for COVID-19 vaccines are conducted in Africa, so that enough data is gathered on the safety and efficacy of vaccine candidates among African populations. It revealed that the consortium is part of the Africa Joint Continental Strategy, for tackling Covid-19,…

Read More